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Some escape from the usual  environmental constraints on growth may be a 
crucial step in  the evolution of a  normal to a  cancer cell.  The possibility that 
many of the recently identified oncogenes code for proteins intimately involved 
in  the  regulation  of normal  cell  growth  provides  a  molecular  basis  for  the 
appropriate phenotypic change (1-3).  Activation of an autocrine loop, whereby 
a cell both secretes and responds to a soluble growth-promoting factor (4), may 
be  one route  to the degree of cellular autonomy necessary for the  cancerous 
state and has been implicated in the continuous growth of a number of cell lines 
(5-7), including those of lymphoid origin harboring the Epstein-Barr virus (EBV) 
genome (8).  EBV  is associated with two human cancers,  nasopharyngeal carci- 
noma and Burkitt's lymphoma, and cell lines established by EBV transformation 
of normal B  lymphocytes may well represent  a  preneoplastic state of the latter 
(9). By generating growth factor activity from such lymphoblastoid cell lines in 
a  defined serum-free medium we have been able to explore the mechanism of 
autostimulatory growth for virally transformed B lymphoblasts. 
Materials and Methods 
The establishment, cloning, and maintenance of EBV-transformed cell lines in serum- 
supplemented RPMI 1640 have been detailed elsewhere (10). For serum-free studies, the 
basal medium throughout was Iscove's modified Dulbecco's medium (Gibco Laboratories, 
Grand  Island,  NY).  Regular supplements included delipidated bovine serum albumin 
(Gibco) at 1 mg/ml, soybean lipids (Gibco) at 20 #g/ml, L-glutamine (200 mM), penicillin/ 
streptomycin (50 #g/ml), and 2-mercaptoethanol (5 x  10  -~ M). Transferrin was obtained 
as an essentially iron-free preparation (Sigma Chemical Co., St. Louis, MO) and used at 
concentrations indicated in the text. 
Conditioned medium (LCL-CM) was collected from lymphoblastoid cells that had been 
taken from their log phase of growth in serum-supplemented medium and transferred, 
after extensive washing, to serum-free conditions with the regular supplements but no 
transferrin. Cells were held at 37°C in a humidified 5% CO~ atmosphere for 18 h at a 
concentration of 2-4 x  105/ml before the harvesting of supernatants. Supernatants were 
passed through a 0.45-#m filter and stored at 4°C before use on the same day. 
Target cells for growth factor assays were always used in autologous combinations with 
LCL-CM and collected by low speed centrifugation from the serum-free conditions. All 
tests  were  performed in  flat-bottomed 96-well  plates  (growth  area  0.32  cm  ~)  in  the 
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regularly  supplemented  basal  medium.  Unless  stated  otherwise,  DNA  synthesis  was 
assessed by pulsing wells for 4 h with [3H]thymidine (1 /~Ci/well, 25 Ci/mmoi) at termi- 
nation of culture with all determinations performed in quadruplicate. Transferrin recep- 
tors were sought using OKT9 (Ortho Diagnostic Systems Inc., Westwoods, MA) in an 
indirect staining procedure  described elsewhere (11).  Fluorescently stained cells were 
analyzed on a Becton-Dickinson FACS IV flow cytometer. 
Results 
All lymphoblastoid cell lines tested revealed an absolute dependency on trans- 
ferrin for their growth in serum-free medium. Other additives to the  Iscove's 
basal medium, namely albumin and iipids, were beneficial rather than essential 
for LCL growth.  A  sigmoidal dose dependency of LCL growth on transferrin 
was noted (Fig. 1 a). By analogy with enzyme kinetics, such a relationship between 
DNA synthesis and concentration of growth-promoting factor has been taken to 
imply cooperativity in cellular proliferation. As this was noted in the absence of 
any  additional  exogenous  activity,  it  implies  that  the  apparent  cooperativity 
relied on an endogenously produced factor. 
It  can  be  noted  (Fig.  1 a)  for cells  at  low density that  no concentration  of 
transferrin was capable of sustaining proliferation,  providing further evidence 
that its growth-promoting effect was dependent on an autogenous product. The 
results depicted in Fig.  1 b demonstrate that this was a  released soluble activity, 
as LCL-CM was able to replace the high cell density requirement for growth. It 
was  also  shown  that  the  growth-promoting  action  of LCL-CM  was,  in  turn, 
absolutely dependent on the presence of transferrin for its effect (Fig.  1 b). At a 
constant transferrin input, [3H]thymidine uptake by lymphoblastoid cells at low 
density exhibited a sigmoidal dose response to LCL-CM concentration. 
The strong interdependence of transferrin and LCL-CM on lymphoblastoid 
cell growth is reemphasized by the results given in Fig. 2. Here, the influence of 
the two activities over a wide range of cell densities is compared with the results 
being expressed in terms of proliferative capacity per cell. It can be seen that the 
efficient growth-promoting activity of transferrin at high cell numbers declined 
abruptly as cell density was decreased in the absence of LCL-CM. While LCL- 
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FIGURE  1.  Requirement for transferrin and an autogenous factor in LCL growth. (a) Cells 
were incubated serum-free at  105 (O) or 104 (O) per ml for 3 d with varying amounts of 
transferrin as indicated. DNA synthesis was assessed by a 4-h [SH]thymidine  pulse at the 
termination of culture. (b) Cells at 104 per ml were incubated with varying concentrations of 
autologous LCL-CM  as indicated in the presence (0) or absence (O) of transferrin at 25 ~,g] 
ml.  DNA  synthesis was assessed as described and shown as the  mean of quadruplicate 
determinations that were always  within 10% of each other. 1556  GORDON  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIGURE 2.  Synergism of transferrin  and  conditioned medium  in  LCL growth.  Cells were 
incubated at the indicated concentration for 3 d in the presence of 50% LCL-CM (I-I), 25 t~g/ 
ml transferrin  (O),  or the two activities together  (©). Absolute  levels of background  [3H]- 
thymidine incorporation ranged  from  78-347  cpm and  were deducted  from incorporation 
obtained in the presence of the growth-promoting activities. 
CM  was unable to provide direct growth support at any cell concentration,  it 
greatly extended  the  critical  cell  density for  transferrin-dependent  growth  so 
that at densities as low as 2 ×  103 cells per ml, significant DNA synthesis was still 
apparent after 3 d in serum-free conditions. 
We designed an experiment in order to ascertain whether the growth-promot- 
ing  activities  of  LCL-CM  and  transferrin  were  required  simultaneously  or 
whether they exerted separate effects sequentially. This necessitated rendering 
cells essentially growth factor-free.  Lymphoblastoid cells taken from their log 
phase of growth in serum-supplemented medium were manipulated by a  series 
of washings and incubations at low cell density in the absence of transferrin, as 
detailed in Fig. 3. Such cells, considered "growth factor-free," were then exposed 
independently to the growth-promoting activities of LCL-CM and transferrin or 
simply returned to control serum-free medium lacking both of these (Stage I). 
Following 16 h of conditioning, cells were washed free of their soluble activities 
and reseeded at low cell density in the presence or absence of fresh LCL-CM or 
transferrin  (Stage  lI).  Assessing DNA  synthesis by a  16-h  [3H]thymidine pulse 
12 h later revealed, unequivocally, that only when cells had been conditioned in 
the presence of LCL-CM were they capable of mounting a proliferative response 
on the addition of transferrin (Fig. 3). Transferrin-conditioned cells showed very 
little [3H]thymidine incorporation when subsequently incubated with LCL-CM. 
The growth-promoting activity of LCL-CM therefore appeared to reside in its 
ability to prime lymphoblastoid cells for responsiveness to transferrin. 
It seemed a  reasonable proposition that the autostimulatory activity of LCL- 
CM  might  act  by  influencing  the  expression  of transferrin  receptors  at  the 
lymphoblast surfaces.  This assumption was tested by taking cells at Stage I  of 
conditioning and staining their surfaces with anti-transferrin  receptor antibody 
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FIGURE 3.  Sequential action of growth-promoting factors on LCL proliferation. Cells were 
placed at 37°C serum-free in the absence of transferrin at a density of 104/ml. At 8,  16, and 
24 h cells were washed thoroughly and resuspended in fresh medium. At 36 h from initiation 
of culture ceils were washed and placed at  10*/ml  in either fresh control medium, medium 
supplemented with  25 tzg/ml of transferrin, or 50%  LCL-CM. Following  16 h incubation at 
37°C (Stage I), cells were washed,  resuspended in fresh control medium (without transferrin) 
at 4 ×  104/ml and  100 ul plated into microwells.  A further  100 t*l of either control medium 
I-I, 100%  LCL-CM  K~, or  medium  containing  50  #g/ml  of transferrin  []  were  added  in 
quadruplicate for each condition and the plate was returned to 37°C (Stage II) for 12 h. Wells 
were then pulsed with [3H]thymidine  for 16 h and DNA synthesis  assessed  (results  given as 
means ___ ISD). 
FIGURE 4.  Influence of conditioned-medium on the expression oftransferrin receptors. Cells 
from Stage I of conditioning (see Fig.  3) were stained with  OKT9 and analyzed on a FACS 
IV. (  ,  ) cells conditioned  in  the  presence of 50%  LCL-CM.  (  ..... ) cells maintained in 
control medium. ( ....... ) control staining (i.e., fluorescent conjugate only).  This was essen- 
tially the same for both  lots of ceils and only the control for LCL-CM conditioned cells is 
shown for clarity. Staining intensity is represented by a linear scale. 
factor-free  and  then  incubated  in  the  presence  of LCL-CM  revealed  an appre- 
ciably  stronger  reactivity  (approximately  threefold)  with  the  OKT9  antibody 
than  cells that  had  been  denied  this growth-promoting  activity. 
Discussion 
This study confirms the recent findings by Blazar et al. (8) that lymphoblastoid 
cell lines display autostimulatory  growth.  We have now extended  these  observa- 
tions by identifying  the  cofactor  requirements  and  suggesting  a  possible  mecha- 
nism  for LCL  growth  in  serum-free  conditions.  Attempts  to isolate  the  growth- 
promoting  activity  of LCL-CM  have  so  far proved  unrewarding,  probably  due 
to an extreme  inherent  stickiness of the factor (unpublished  observations,  and  B. 
Blazar,  personal  communication).  We  also  have  no  molecular  characterization 
save that the activity is retained  by dialysis tubing of molecular weight  exclusion 
>2,000.  All  LCL-CM  so  far  tested  do,  however,  possess  potent  BCGF  (B-cell 
growth  factor)  activity  (12)  as judged  by  their  ability  to  synergize  with  Fab'2 
fragments  of anti-immunoglobulin  in  stimulating  small resting  B  lymphocytes to 
DNA  synthesis  (manuscript  in  preparation).  It is tempting  to speculate  that  it  is 
this same BCGF activity that sustains  LCL growth.  The  EBV could therefore  be 1558  GORDON  ET  AL.  BRIEF  DEFINITIVE  REPORT 
envisaged as serving two distinct, but absolutely essential, functions during B 
lymphocyte transformation. The first of these, by analogy to physiologic (i.e., 
anti-Ig) activation, would be to induce the appearance of receptors for BCGF at 
the surfaces of small resting B cells. The second, and possibly the physiologically 
inappropriate feature of EBV transformation, would be the induction of a BCGF 
activity either coded directly from the viral genome or through the activation of 
an otherwise phenotypically silent cellular gene. Experiments designed to explore 
these possibilities are currently underway in our laboratory. 
Autostimulatory growth is clearly not unique to virally transformed B lympho- 
cytes, nor indeed to cells of lymphoid origin (4-7). On the contrary, the induction 
of an autocrine loop may be a  quite regular pathway to cellular immortality, 
sometimes being reached by viral infection but also via other routes such as the 
activation of oncogenes coding for autostimulatory products. The relationship 
between EBV and the development of Burkitt's lymphoma in endemic regions 
has been extensively covered by Nilsson and Klein in a recent review (9).  Our 
findings offer a functional basis for one of the postulated key steps in the multi- 
stage evolution of a  Burkitt cell.  By itself,  the endowment of immortality is 
clearly not sufficient, but is probably a prerequisite, for the neoplastic state. A 
vital additional element for full tumorigenicity may be some phenotypic alteration 
that would allow the necessary escape from host regulation. 
The observed degree of autonomy in the growth of virally transformed B 
lymphoblasts was,  in fact,  quite remarkable.  Transferrin was found to be the 
only essential exogenous factor. The requirement for transferrin in the growth 
of lymphoid and nonlymphoid cells is well established with the molecule probably 
involved in complexing and transporting iron into the cell (13, 14). Intriguingly, 
our observations on LCL growth find close parallel with a recent report on the 
mitogen-induced activation of human T  lymphocytes (15).  Here,  the authors 
argued for a sequential appearance of growth factor receptors with the role of 
interleukin 2 being the induction of transferrin receptors on the mitogen-primed 
T  cells,  permitting their entry into the S phase of the cycle on the subsequent 
binding  to  transferrin  molecules.  It  remains  to  be  determined whether  an 
analogous pathway exists for the physiological activation of normal B lympho- 
cytes, but our findings clearly point to such a possibility. 
Summary 
B lymphoblasts immortalized by the Epstein-Barr virus (EBV) exhibit autocrine 
growth stimulation--that is they release a soluble activity to which they respond 
by growth. A minimally supplemented serum-free medium conditioned by lym- 
phoblastoid cells in their log phase of growth (LCL-CM) was found to contain 
autostimulatory activity  allowing  us  to  explore  the  mechanism of autocrine 
growth for these cell-types in defined conditions. Below cell densities capable of 
supporting autonomous growth, continued proliferation in serum-free medium 
was dependent on both added LCL-CM and transferrin. Neither activity alone 
was capable of sustaining growth. At higher cell densities, transferrin by itself 
was sufficient to maintain the autocrine loop. The action of the autostimulatory 
factor appeared to reside in its ability to prime cells continually for a proliferative 
response to transferrin by enhancing the expression of transferrin receptors at 
the lymphoblast surfaces. The implications of these findings for normal B cell 
physiology and their possible relation to oncogenesis are discussed. GORDON  ET  AL.  BRIEF  DEFINITIVE  REPORT  1559 
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